Search for: "Taylor v. Eli Lilly and Company" Results 1 - 11 of 11
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
5 Oct 2022, 6:51 am by Dennis Crouch
” In re Eli Lilly and Co., 37 F.4th 160 (4th Cir. 2022). [read post]
20 Dec 2023, 5:00 am by Timothy Bonis
Major industry players filed amici briefs on both sides, AbbVie, Bristol Meyers Squibb, and Merck supporting Amgen, and Pfizer, Eli Lilly, Genentech, and AstraZeneca supporting Sanofi. [read post]
10 Jun 2014, 7:44 pm
 In this post, guest contributor Paul England (Taylor Wessing LLP) explains the legal issues and their consequences:UKIPO -- a 'court' for the purposes of the Brussels I Regulation Some courts look like this ...With Actavis v Eli Lilly [noted on the IPKat here] still fresh in our minds, and amendments to the Brussels I Regulation (recast) progressing through the European Parliament in preparation for the Unified Patent Court, jurisdictional… [read post]
10 Feb 2010, 11:56 am by Beck, et al.
Eli Lilly & Co., 485 N.E.2d 551, 553 (Ill. [read post]
14 Jun 2007, 12:57 am
Eli Lilly: Lawyers' Ads Are Hurting Patients The Associated Press Eli Lilly and Co., which has faced thousands of suits over its anti-psychotic Zyprexa, says lawyers' ads about the drug are prompting patients to stop taking mental illness medications when they shouldn't. [read post]
24 Feb 2011, 1:49 pm by Bexis
The complicated medical terminology necessary to explain the risk/benefit profile of prescription drugs/devices is difficult for ordinary patients to understand.Practical difficulties often preclude drug/device companies from direct communication with patients.But plaintiffs don’t make direct-to-patient warning claims only against drug/device companies. [read post]
6 Jul 2007, 4:29 am
Thus, at best, Karl has just created a regime of redundant and overlapping liability with the patients stuck in the middle - not knowing whom to believe if doctors and drug companies say different things.The learned intermediary rule thus makes sound practical sense. [read post]
9 May 2008, 10:30 pm
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Order to transfer myspace.co.uk to MySpace overturned: (Out-Law), (IMPACT), New branding scheme for Ethiopian coffees: (Afro-IP), (IP finance), (IPKat), USPTO to appeal Tafas/GSK v Dudas: (Patent Docs), (Patently-O), (PLI), (Patent Baristas), (Managing Intellectual Property), (IP Law360), (Patent Prospector), (Ladas & Parry),… [read post]